USPTO serial 97272228
ALFIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 14, 2023
- Examiner
- FICKES, JERI J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ALFIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane J. Mason
Diane J. Mason FAEGRE DRINKER BIDDLE & REATH LLPFOUR EMBARCADERO CENTER, 27TH FLOORSAN FRANCISCO, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded computer software for laboratory instruments and devices for detecting sample presence or concentration for the analysis of bodily fluids; portable fluorescent scanner for laboratory use for detecting presence or concentration of analytes in biological samples containing serum, plasma, blood samples, urine, cerebrospinal fluid, saliva, and stool; recorded computer software for data processing for use in medical research and diagnostics fields; physical and chemical laboratory apparatus and instruments for biological sample processing used for molecular diagnosis for laboratory use; physical and chemical laboratory apparatus and instruments used for molecular diagnosis for laboratory use; apparatus and devices for nonmedical biological sample tests for biomarker analysis, immune-assay-based diagnosis for laboratory use, and cell biology research for laboratory use; automated analysis devices for non-medical biological samples for body fluid analysis; Laboratory diagnostic apparatus and devices not for medical purposes for in vitro diagnostic testing and analysis of body fluid samples; recorded computer software for displaying data generated by medical examination and diagnostic devices; recorded computer software for analyzing data generated by medical examination and diagnostic devices; computer hardware used with medical examination and diagnostic devices; recorded computer software used for medical examination and diagnosis; physical and chemical laboratory apparatus and instruments for body fluid sample processing used for in vitro diagnosis of diseases for laboratory use; physical and chemical laboratory apparatus and instruments used for in vitro diagnosis of diseases for scientific and research purposes; computer data processing devices and equipment and their computer components and parts, namely, replacement parts for use in medical research and diagnostics field; computer data processing devices and equipment and their computer components and parts, namely, computer peripherals and hardware for use in medical research and diagnostics field; recorded computer software and computer hardware for use in the field of medical diagnostics; recorded computer software for apparatus and devices for measurement or analysis of fluorescence signals; apparatus and devices for measuring fluorescent signals for scientific and research purposes; apparatus and devices for measuring absorbance for scientific and research purposes; recorded computer software for apparatus and devices for measuring absorbance; laboratory filters for detecting presence or concentration of analytes in biological samples containing serum, plasma, blood samples, urine, cerebrospinal fluid, saliva, and stool; laboratory distillation apparatus for detecting presence or concentration of analytes in biological samples containing serum, plasma, blood samples, urine, cerebrospinal fluid, saliva, and stool; laboratory reagent cartridges sold empty used in apparatus for detecting sample presence or concentration; reagent cartridges sold empty for non-medical research immunoassay devices used for molecular diagnosis; reagent cartridges sold empty used in non-medical immunoassay devices; reagent cartridges sold empty used in non-medical immunoassay-based diagnosis; reagent cartridges sold empty used in non-medical in vitro diagnostic devices; reagent cartridges sold empty used in non-medical biological sample analysis devices; reagent cartridges sold empty for non-medical research immunoassay devices used for in vitro diagnosis; apparatus and devices for non-medical fluorescent signal analysis of laboratory samples | ACTIVE | Jul 19, 2019 |
| 010 | Medical diagnostic apparatus for biological sample processing used for immunoassay-based diagnosis; medical diagnostic devices, namely, cartridges for detecting chemical composition and measuring concentration of chemicals in medical specimens being liquid biological samples; immunoassay devices for medical purposes, namely, medical diagnostic instruments for the analysis of body fluids; Immunoassay cartridges for immunoassay-based diagnosis for determining the concentration of target analytes in body fluids for medical purpose; molecular diagnosis apparatus, namely, medical diagnostic apparatus for detecting fertility, cardiac disease, tumor, hormone levels, diabetes, infectious disease, rheumatoid arthritis, sepsis, anemia, ferritin and vitamin D for medical purposes; cartridges for molecular diagnosis for determining the concentration of target analytes in body fluids for medical purpose; biological sample testing instruments and devices for medical purposes for the analysis of body fluids; biological sample analyzing cartridges for medical purposes for the analysis of body fluids; biological sample auto analysis apparatus for medical purposes for the analysis of body fluids; instruments and devices for processing biological sample for medical purpose, namely, apparatus for body fluid analysis; devices for medical purposes, namely, apparatus for blood analysis; medical diagnostic devices for the analysis of body fluids; diagnostic devices for medical purposes, namely, blood analysis apparatus for medical diagnostic purposes; in vitro diagnosis device for medical purposes, namely, medical diagnostic instruments for the analysis of body fluids; in vitro diagnostic cartridges for immunoassay-based diagnosis for determining the concentration of target analytes in body fluids for medical purpose; immunofluorescence analysis apparatus for medical purposes; fluorescent signal processing devices for medical purposes; apparatus for absorption analysis for medical purpose, namely, apparatus for body fluid analysis; Immunoassay cartridges for molecular diagnosis for determining the concentration of target analytes in body fluids for medical purpose; immunoassay cartridges for medical purposes, namely, medical diagnostic instruments for in vitro diagnosis of body fluids; physical and chemical medical apparatus and instruments for biological sample processing for use in the field of medical examination and diagnosis | ACTIVE | Jul 19, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 14, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 27, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 27, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 27, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 27, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2022 | NWAP | NEW APPLICATION ENTERED | — |